Monday December 10, 2018
Home Uncategorized Cancer risks ...

Cancer risks associated with X-rays, CT scans are only theoretical: Study

0
//
Republish
Reprint

New York: The widespread belief that radiations from X-rays and CT scans can cause cancer has flaws and is based on an unproven theoretical model, suggests a study.

To estimate cancer risk from low-dose radiation, scientists used a model known as linear no-threshold (LNT) in the study published in the American Journal of Clinical Oncology.

But risk estimates based on this model “are only theoretical and, as yet, have never been conclusively demonstrated by empirical evidence”, wrote researcher James Welsh from the Loyola University in Chicago.

The use of the LNT model drives unfounded fears and “excessive expenditures on putative but unneeded and wasteful safety measures”, Welsh noted.

In the LNT model, the well-established cancer-causing effects of high doses of radiation are extended downward in a straight line to very low doses.

The model dissuades many physicians from using appropriate imaging techniques and “discourages many in the public from getting proper and needed imaging, all in the name of avoiding any radiation exposure”, the researcher explained.

This model assumes there is no safe dose of radiation, no matter how small.

However, the human body has evolved the ability to repair damage from low-dose radiation that naturally occurs in the environment.

Studies of atomic bomb survivors and other epidemiological studies of human populations have never conclusively demonstrated that low-dose radiation exposure can cause cancer, according to the study.

Any claim that low-dose radiation from medical imaging procedures is known to cause cancer “should be vigorously challenged, because it serves to alarm and perhaps harm, rather than educate”, the scientists suggested.

The LNT model “should finally and decisively be abandoned”, the authors concluded. (IANS)(Photo: www.continentalhospitals.com)

Click here for reuse options!
Copyright 2016 NewsGram

Next Story

World’s Smallest Wearable Can Help in Preventing Skin Cancer

It also demonstrated the ability to measure white light exposure for seasonal depression, a mood disorder characterised by depression that occurs at the same time every year

0
cancer
World's smallest device to prevent skin cancer, mood disorder risk. Pixabay

Scientists have developed the world’s smallest wearable, battery-free device that can warn people of overexposure to ultraviolet rays (UV) — a leading factor for developing skin cancer.

Currently, people do not know how much UV light they are actually getting. The rugged and waterproof device interacts wirelessly with the phone and helps maintain an awareness and for skin cancer survivors.

Smaller than an M&M (colourful button-shaped chocolates) and thinner than a credit card, the device can optimise treatment of neonatal jaundice, skin diseases, seasonal affective disorder and reduce risk of sunburns and skin cancer.

Users can glue the device on to their hats, clip it to sunglasses or stick it on their nail and can simultaneously record up to three separate wavelengths of light.

It is always on yet never needs to be recharged.

“There is a critical need for technologies that can accurately measure and promote safe UV exposure at a personalised level in natural environments,” said Steve Xu, from Northwestern University in the US.

Cancer
Cancer Ribbon. Pixabay

“We hope people with information about their UV exposure will develop healthier habits when out in the sun,” said Xu.

There are no switches or interfaces to wear out, and it is completely sealed in a thin layer of transparent plastic, the researchers stated, in the paper published in the journal Science Translational Medicine.

Participants who mounted device on themselves recorded multiple forms of light exposure during outdoor activities, even in the water.

Also Read- First NASA Probe to Return Asteroid Sample Reaches Destination

The findings showed that it monitored therapeutic UV light in clinical phototherapy booths for psoriasis and atopic dermatitis (immune diseases) as well as blue light phototherapy for newborns with jaundice in the neonatal intensive care unit.

It also demonstrated the ability to measure white light exposure for seasonal depression, a mood disorder characterised by depression that occurs at the same time every year. (IANS)